SIGN 97: Risk estimation and the prevention of cardiovascular disease

Guideline Index Page | SIGN Methodology


ACE angiotensin converting enzyme
AHA American Heart Association
ARB angiotensin-II receptor antagonist
ASCOT-BPLA Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering Arm
ASH Action on Smoking and Health
ASSIGN ASsessing cardiovascular risk using SIGN guidelines to ASSIGN preventive treatment
AST aspartate aminotransferase
ATP Adult Treatment Panel
BC behavioural counselling
BHS British Hypertension Society
BIP Bezafibrate Infarction Prevention
BMI body mass index
BP blood pressure
CAIUS Carotid Atherosclerosis Italian Ultrasound Study
CAIUS Collaborative Atorvastatin Diabetes Study
CBT cognitive behavioural therapy
CCB calcium channel blocker
CHD coronary heart disease
CI confidence interval
CK creatine kinase
CRP c-reactive protein
CV cardiovascular
CVD cardiovascular disease
DM diabetes mellitus
ECG electrocardiogram
ETS environmental tobacco smoke
FIELD Fenofibrate Intervention and Event Lowering in Diabetes
GFR glomerular filtration rate
GP general practitioner
HATS HDL-Atherosclerosis Treatment Study
HDL high density lipoprotein
HHS Helsinki Heart Study
HIV human immunosuppressive virus
HOT Hypertension Outcomes Trial
IDF International Diabetes Federation
IHD ischaemic heart disease
IR immediate release
JBS Joint British Societies
JBS2 Joint British Societies' Guideline on Prevention of Cardiovascular Disease in Clinical Practice
LDL low density lipoprotein
METS metabolic equivalents
MI myocardial infarction
MR modified release
NHLBI National Heart, Lung, and Blood Institute
NHS National Health Service
NHSQIS NHS Quality Improvement Scotland
NICE National Institute for Health and Clinical Excellence
NRT nicotine replacement therapy
OR odds ratio
PAD peripheral arterial disease
PPP Primary Prevention Project
QALY quality adjusted life year
RCT randomised controlled trial
RR relative risk
SHHEC Scottish Heart Health Extended Cohort
SIGN Scottish Intercollegiate Guidelines Network
SIMD Scottish index of multiple deprivation
SM stress management
SMAC Standing Medical Advisory Committee
SMC Scottish Medicines Consortium
TC total cholesterol
TG triglycerides
TIA transient ischaemic attack
UK United Kingdom
VA-HIT Veterans Affairs HDL Intervention
WHO World Health Organisation


Guideline Index Page | SIGN Methodology

Scottish Intercollegiate Guidelines Network, Healthcare Improvement Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB
Tel. 0131 623 4720 Web contact
Last modified 13/09/13 © SIGN 2001-2013

Risk estimation and the prevention of CHD <Guidelines <Home